Asthma medication delivery: Mists and myths

Paediatric Respiratory Reviews

Volumn 14, Issue 2, 2013, Pages 112-118

  Rottier, Bart L ^a   Rubin, Bruce K ^b  

^a UNIVERSITY OF GRONINGEN   (Netherlands)

^b VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Aerosol; Dry powder inhaler; Lung deposition; Nebulizer; Pressurized metered dose inhaler

Indexed keywords

BECLOMETASONE; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BRONCHODILATING AGENT; CORTICOSTEROID; FLUNISOLIDE; MOMETASONE FUROATE; SALBUTAMOL; TOBRAMYCIN;

AEROSOL; AIRWAY; ASTHMA; BODY WEIGHT; CRYING; CYSTIC FIBROSIS; DIFFUSION; DRUG DELIVERY SYSTEM; DRUG TARGETING; DRY POWDER INHALER; HUMAN; INHALATION MANOEUVRE; INHALATION SPACER; INTENSIVE CARE UNIT; INTERMETHOD COMPARISON; MEDICAL PROCEDURES; METERED DOSE INHALER; NEBULIZER; PARTICLE SIZE; PATIENT COMPLIANCE; PEAK INSPIRATORY FLOW; PRIORITY JOURNAL; REVIEW; SEDIMENTATION; CHILD; INHALATIONAL DRUG ADMINISTRATION; TREATMENT OUTCOME;

ADMINISTRATION, INHALATION; ADRENAL CORTEX HORMONES; ASTHMA; BRONCHODILATOR AGENTS; CHILD; DRY POWDER INHALERS; HUMANS; METERED DOSE INHALERS; TREATMENT OUTCOME;

EID: 84878592879     PISSN: 15260542     EISSN: 15260550     Source Type: Journal    
DOI: 10.1016/j.prrv.2013.02.013     Document Type: Review

References (62)

1. British Guideline on the Management of Asthma. Thorax 2008; 63 Suppl 4:iv1-121.
2. 2010. GINA. (at ). http://www.ginasthma.org/pdf/GINA_Pocket_2010a.pdf.
3. Rottier B.L., Duiverman E.J. Anti-inflammatory drug therapy in asthma. Paediatr Respir Rev 2009, 10:214-219.
4. Kraft M., Djukanovic R., Wilson S., Holgate S.T., Martin R.J. Alveolar tissue inflammation in asthma. Am J Respir Crit Care Med 1996, 154:1505-1510.
5. Hamid Q., Song Y., Kotsimbos T.C., et al. Inflammation of small airways in asthma. J Allergy Clin Immunol 1997, 100:44-51.
6. Adcock I.M., Gilbey T., Gelder C.M., Chung K.F., Barnes P.J. Glucocorticoid receptor localization in normal and asthmatic lung. Am J Respir Crit Care Med 1996, 154:771-782.
7. Davies A MC. Airflow in the respiratory system. In: Anonymous The respiratory system, basic science and clinical conditions. Churchill Livingstone: 51-53.
8. Camargos P.A., Rodrigues M.E., Lasmar L.M. Simultaneous treatment of asthma and allergic rhinitis. Pediatr Pulmonol 2004, 38:186-192.
9. Camargos P., Ibiapina C., Lasmar L., Cruz A.A. Obtaining concomitant control of allergic rhinitis and asthma with a nasally inhaled corticosteroid. Allergy 2007, 62:310-316.
10. Laube B.L., Janssens H.M., de Jongh F.H., et al. ERS/ISAM task force consensus statement. Eur Respir J 2011.
11. Usmani O.S., Biddiscombe M.F., Barnes P.J. Regional lung deposition and bronchodilator response as a function of beta2-agonist particle size. Am J Respir Crit Care Med 2005, 172:1497-1504.
12. Zeman K.L., Wu J., Bennett W.D. Targeting aerosolized drugs to the conducting airways using very large particles and extremely slow inhalations. J Aerosol Med Pulm Drug Deliv 2010, 23:363-369.
13. Zar H.J., Asmus M.J., Weinberg E.G. A 500-ml plastic bottle: an effective spacer for children with asthma. Pediatr Allergy Immunol 2002, 13:217-222.
14. Zar H., Brown G., Donson H. Are spacers made from sealed cold-drink bottles as effective as conventional spacers?. West J Med 2000, 173:253.
15. Willemse B.W., Toelle B.G., Li J.S., Shah S., Peat J.K. Use of a paper disposable cup as a spacer is effective for the first-aid management of asthma. Respir Med 2003, 97:86-89.
16. Rodriguez C., Sossa M., Lozano J.M. Commercial versus home-made spacers in delivering bronchodilator therapy for acute therapy in children. Cochrane Database Syst Rev 2008, CD005536.
17. Juniper E.F., Price D.B., Stampone P.A., Creemers J.P., Mol S.J., Fireman P. Clinically important improvements in asthma-specific quality of life, but no difference in conventional clinical indexes in patients changed from conventional beclomethasone dipropionate to approximately half the dose of extrafine beclomethasone dipropionate. Chest 2002, 121:1824-1832.
18. Price D., Martin R.J., Barnes N., et al. Prescribing practices and asthma control with hydrofluoroalkane-beclomethasone and fluticasone: a real-world observational study. J Allergy Clin Immunol 2010, 126. 511,8.e1-10.
19. Cohen J., Postma D.S., Douma W.R., Vonk J.M., De Boer A.H., ten Hacken N.H. Particle size matters: diagnostics and treatment of small airways involvement in asthma. Eur Respir J 2011, 37:532-540.
20. Busse W.W., Brazinsky S., Jacobson K., et al. Efficacy response of inhaled beclomethasone dipropionate in asthma is proportional to dose and is improved by formulation with a new propellant. J Allergy Clin Immunol 1999, 104:1215-1222.
21. Micheletto C., Guerriero M., Tognella S., Dal Negro R.W. Effects of HFA- and CFC-beclomethasone dipropionate on the bronchial response to methacholine (MCh) in mild asthma. Respir Med 2005, 99:850-855.
22. Leach C.L., Davidson P.J., Hasselquist B.E., Boudreau R.J. Influence of particle size and patient dosing technique on lung deposition of HFA-beclomethasone from a metered dose inhaler. J Aerosol Med 2005, 18:379-385.
23. Leach C.L., Bethke T.D., Boudreau R.J., et al. Two-dimensional and three-dimensional imaging show ciclesonide has high lung deposition and peripheral distribution: a nonrandomized study in healthy volunteers. J Aerosol Med 2006, 19:117-126.
24. Leach C.L., Davidson P.J., Hasselquist B.E., Boudreau R.J. Lung deposition of hydrofluoroalkane-134a beclomethasone is greater than that of chlorofluorocarbon fluticasone and chlorofluorocarbon beclomethasone: a cross-over study in healthy volunteers. Chest 2002, 122:510-516.
25. Newman S.P., Pitcairn G.R., Hirst P.H., et al. Scintigraphic comparison of budesonide deposition from two dry powder inhalers. Eur Respir J 2000, 16:178-183.
26. Newhouse M.T., Hirst P.H., Duddu S.P., et al. Inhalation of a dry powder tobramycin PulmoSphere formulation in healthy volunteers. Chest 2003, 124:360-366.
27. Pitcairn G.R., Lim J., Hollingworth A., Newman S.P. Scintigraphic assessment of drug delivery from the Ultrahaler dry powder inhaler. J Aerosol Med 1997, 10:295-306.
28. Rottier B.L., de Boer A.H., Duiverman E.J. Inhaled medication and inhalation devices for lung disease in patients with cystic fibrosis: three areas for future research Which areas to target? Which particle size to deliver? Which device to use?. J Cyst Fibros 2010, 9:296-297.
29. Kim C.S., Kang T.C. Comparative measurement of lung deposition of inhaled fine particles in normal subjects and patients with obstructive airway disease. Am J Respir Crit Care Med 1997, 155:899-905.
30. Rottier B.L., van Erp C.J., Sluyter T.S., Heijerman H.G., Frijlink H.W., Boer A.H. Changes in performance of the Pari eFlow rapid and Pari LC Plus during 6 months use by CF patients. J Aerosol Med Pulm Drug Deliv 2009, 22:263-269.
31. Rottier B., Grasmeijer F., Hagedoorn P., de Boer A.H. Aerosol drug delivery: developments in device design and clinical use. Lancet 2011, 378:981. 2; author reply 982.
32. Roller C.M., Zhang G., Troedson R.G., Leach C.L., Le Souef P.N., Devadason S.G. Spacer inhalation technique and deposition of extrafine aerosol in asthmatic children. Eur Respir J 2007, 29:299-306.
33. Iles R., Lister P., Edmunds A.T. Crying significantly reduces absorption of aerosolised drug in infants. Arch Dis Child 1999, 81:163-165.
34. Murakami G., Igarashi T., Adachi Y., et al. Measurement of bronchial hyperreactivity in infants and preschool children using a new method. Ann Allergy 1990, 64:383-387.
35. Janssens H.M., van der Wiel E.C., Verbraak A.F., de Jongste J.C., Merkus P.J., Tiddens H.A. Aerosol therapy and the fighting toddler: is administration during sleep an alternative?. J Aerosol Med 2003, 16:395-400.
36. Esposito-Festen J., Ijsselstijn H., Hop W., van Vliet F., de Jongste J., Tiddens H. Aerosol therapy by pressured metered-dose inhaler-spacer in sleeping young children: to do or not to do?. Chest 2006, 130:487-492.
37. Janssens H.M., Tiddens H.A. Facemasks and aerosol delivery by metered dose inhaler-valved holding chamber in young children: a tight seal makes the difference. J Aerosol Med 2007, 20(Suppl 1):S59. 63; discussion S63-5.
38. Smaldone G.C., Berg E., Nikander K. Variation in pediatric aerosol delivery: importance of facemask. J Aerosol Med 2005, 18:354-363.
39. Rubin B.K. Bye-bye, blow-by. Respir Care 2007, 52:981.
40. Tal A., Golan H., Grauer N., Aviram M., Albin D., Quastel M.R. Deposition pattern of radiolabeled salbutamol inhaled from a metered-dose inhaler by means of a spacer with mask in young children with airway obstruction. J Pediatr 1996, 128:479-484.
41. Onhoj J., Thorsson L., Bisgaard H. Lung deposition of inhaled drugs increases with age. Am J Respir Crit Care Med 2000, 162:1819-1822.
42. Castro-Rodriguez J.A., Rodrigo G.J. Beta-Agonists through Metered-Dose Inhaler with Valved Holding Chamber Versus Nebulizer for Acute Exacerbation of Wheezing Or Asthma in Children Under 5 Years of Age: a Systematic Review with Meta-Analysis. J Pediatr 2004, 145:172-177.
43. Travers A., Jones A.P., Kelly K., Barker S.J., Camargo C.A., Rowe B.H. Intravenous beta2-agonists for acute asthma in the emergency department. Cochrane Database Syst Rev 2001, (2). CD002988.
44. Jones A., Rowe B., Peters J., Camargo C., Hammarquist C., Rowe B. Inhaled beta-agonists for asthma in mechanically ventilated patients. Cochrane Database Syst Rev 2001, (4). CD001493.
45. Guerin C., Fassier T., Bayle F., Lemasson S., Richard J.C. Inhaled bronchodilator administration during mechanical ventilation: how to optimize it, and for which clinical benefit?. J Aerosol Med Pulm Drug Deliv 2008, 21:85-96.
46. Kamps A.W., Brand P.L., Roorda R.J. Determinants of correct inhalation technique in children attending a hospital-based asthma clinic. Acta Paediatr 2002, 91:159-163.
47. Giraud V., Allaert F.A., Roche N. Inhaler technique and asthma: feasability and acceptability of training by pharmacists. Respir Med 2011, 105:1815-1822.
48. Brennan V.K., Osman L.M., Graham H., Critchlow A., Everard M.L. True device compliance: the need to consider both competence and contrivance. Respir Med 2005, 99:97-102.
49. de Vries T.W., Rottier B.L., Gjaltema D., Hagedoorn P., Frijlink H.W., de Boer A.H. Comparative in vitro evaluation of four corticosteroid metered dose inhalers: Consistency of delivered dose and particle size distribution. Respir Med 2009, 103:1167-1173.
50. van der Giessen L.J., de Jongste J.C., Gosselink R., Hop W.C., Tiddens H.A. RhDNase before airway clearance therapy improves airway patency in children with CF. Pediatr Pulmonol 2007, 42:624-630.
51. Fitzgerald D.A., Hilton J., Jepson B., Smith L. A crossover, randomized, controlled trial of dornase alfa before versus after physiotherapy in cystic fibrosis. Pediatrics 2005, 116:e549-e554.
52. Burchett D.K., Darko W., Zahra J., Noviasky J., Probst L., Smith A. Mixing and compatibility guide for commonly used aerosolized medications. Am J Health Syst Pharm 2010, 67:227-230.
53. Osterberg L., Blaschke T. Adherence to medication. N Engl J Med 2005, 353:487-497.
54. Suissa S., Ernst P., Benayoun S., Baltzan M., Cai B. Low-dose inhaled corticosteroids and the prevention of death from asthma. N Engl J Med 2000, 343:332-336.
55. Stanford R.H., Gilsenan A.W., Ziemiecki R., Zhou X., Lincourt W.R., Ortega H. Predictors of uncontrolled asthma in adult and pediatric patients: analysis of the Asthma Control Characteristics and Prevalence Survey Studies (ACCESS). J Asthma 2010, 47:257-262.
56. Rubin B.K., Pohanka V. Beyond the guidelines: fatal and near-fatal asthma. Paediatr Respir Rev 2012, 13:106-111.
57. Bracken M., Fleming L., Hall P., et al. The importance of nurse-led home visits in the assessment of children with problematic asthma. Arch Dis Child 2009, 94:780-784.
58. Burgess S., Sly P., Devadason S. Adherence with preventive medication in childhood asthma. Pulm Med 2011, 2011:973849.
59. Vaessen-Verberne A.A., van den Berg N.J., van Nierop J.C., et al. Combination therapy salmeterol/fluticasone versus doubling dose of fluticasone in children with asthma. Am J Respir Crit Care Med 2010, 182:1221-1227.
60. Rubin B.K. What does it mean when a patient says, " my asthma medication is not working?" . Chest 2004, 126:972-981.
61. Swedlund M.P., Schumacher J.B., Young H.N., Cox E.D. Effect of Communication Style and Physician-Family Relationships on Satisfaction With Pediatric Chronic Disease Care. Health Commun 2011.
62. van Staveren R. Shared decision-making in medical practice--patient-centred communication skills. Ned Tijdschr Geneeskd 2011, 155:A3777.